Skip to content

A cohort study to explore the factors affecting the progression of pulmonary ground glass nodules

A clinical cohort study of early stage lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071646
Enrollment
Unknown
Registered
2023-05-22
Start date
2023-05-22
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Primary single lung cancer group:N/A
Primary multiple lung cancer group:N/A
Multiple primary cancer group:N/A
Lower age lung cancer group:N/A

Sponsors

Suzhou Hospital Affiliated to Nanjing Medical University(East Area)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ( 1 ) Primary single lung cancer cases, inclusion criteria : primary single lung cancer, no previous history of cancer ; no history of radiotherapy and chemotherapy, no tumor targeted drugs and surgical treatment ; ( 2 ) Primary multiple lung cancer cases, inclusion criteria : primary multiple lung cancer, requiring at least 2 pulmonary nodules to reach AIS ( adenocarcinoma in situ ) ; the remaining requirements are the same as ( 1 ) ( 3 ) Multiple primary cancer cases, inclusion criteria : patients with a history of cancer, primary lung cancer ; the remaining requirements are the same as ( 1 ) ( 4 ) young lung cancer cases, inclusion criteria : patients younger than 50 years old, the remaining requirements are the same as ( 1 )

Exclusion criteria

Exclusion criteria: ( 1 ) Small cell lung cancer cases ( 2 ) Cases of lung cancer treated by surgery, radiotherapy, chemotherapy and tumor targeted drugs ( 3 ) Non-early lung cancer cases

Design outcomes

Primary

MeasureTime frame
Lung function;Blood biochemical indexes;

Countries

China

Contacts

Public ContactYang Yong

Suzhou Hospital Affiliated to Nanjing Medical University(East Area)

337914338@qq.com+86 138 6206 8856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026